89. PHARMACOGENOMICS AND PHARMACOTRANSCRIPTOMICS OF ANTIPSYCHOTIC-INDUCED HYPERCHOLESTEROLEMIA IN 58,000 VETERANS
Hamed Kazemi(University of Arizona), Ayman H. Fanous(University of Arizona), Silviu‐Alin Bacanu, Sutanay Choudhury, Philip D. Harvey(University of Miami), Benjamin McMahon(Los Alamos National Laboratory), John H. Drake(University of Arizona), Vladimir Vladimirov(Pyatigorsk Oncology Center), Julie Kreyenbuhl(University of Maryland, Baltimore), Stephen R. Marder(West Los Angeles College), Hamed Abbaszadegan(Phoenix VA Health Care System), Khushbu Agarwal, Alejandro Zuniga(Pacific Northwest National Laboratory), Sayera Dhaubhadel(Los Alamos National Laboratory)
Cited by 0
Related Papers
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
|The Lancet|2011|1.1k
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|781